CORC

在结果中检索

CORC

浏览/检索结果: 共13条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/04
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
Journal of Gastroenterology and Hepatology, 2018, 卷号: Vol.33 No.6, 页码: 1168-1176
作者:  Wei, L;  Xie, Q;  Hou, JL;  Jia, JD;  Li, W
收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6, 页码: 1168-1176
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/11
MAKALU: Twelve-week of treatment with ritonavir-boosted danoprevir pluzs peginterferon and ribavirin produces 96% SVR12 in HCV genotype 1-infected non-cirrhotic chinese patients 期刊论文
Hepatology International, 2017, 卷号: 11
作者:  Zheng S., Hua R., Xie Q., Feng B., Yang Y., Zhang D., Mao Q., Yang Z., Lin M., Zhang L., Tang H., Duan Z., Wang M., Zhuang Y., Yu H., Wang Z., Gao H., Mei L., Luo B., Wu J.J., Niu J., Wei L.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Sustained Virological Response 12 Weeks after Therapy (SVR12) with Direct-Acting Antivirals (DAA) in Select Asian Populations with Chronic Hepatitis C Genotype 1 (HCV GT 1): A Meta-Analysis of Real-World Effectiveness from Asia 会议论文
作者:  Ji, Fanpu;  Wei, Bin;  Yeo, Yee Hui;  Zou, Biyao;  Ogawa, Eiichi
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/26
Real-world Effectiveness (RWE) of Sofosbuvir plus Ribavirin (SOF plus RBV) Chronic Hepatitis C Genotype 2 (CHC GT 2) in Asia: A Systemic Review and Meta-analysis of Pooled SVR12 会议论文
作者:  Wei, Bin;  Ji, Fanpu;  Yeo, Yee Hui;  Zou, Biyao;  Ogawa, Eiichi
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/26

©版权所有 ©2017 CSpace - Powered by CSpace